Small molecule inhibitors of kynurenine-3-monooxygenase

Details Small molecule inhibitors of kynurenine-3-monooxygenase Small molecule inhibitors of kynurenine-3-monooxygenase

2007-08-16

2011-12-06

Powers, Fiona T (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S363000, C548S128000, C548S136000

Reexamination Certificate

active

08071631

ABSTRACT:
The present invention relates to compounds of Formula I below and their tautomers or pharmaceutically acceptable salts, compositions and methods of uses thereof:

REFERENCES:
patent: 2921066 (1960-01-01), Worffel et al.
patent: 3010872 (1961-11-01), Worffel et al.
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5877193 (1999-03-01), Cesura et al.
patent: 5958910 (1999-09-01), Cesura et al.
patent: 6191170 (2001-02-01), Medina
patent: 6207709 (2001-03-01), Varasi et al.
patent: 6583161 (2003-06-01), Medina
patent: 6645909 (2003-11-01), Fujita et al.
patent: 7173030 (2007-02-01), Pyring et al.
patent: 7183276 (2007-02-01), Sakai et al.
patent: 2003/0130258 (2003-07-01), Kurz et al.
patent: 2005/0009821 (2005-01-01), Pyring et al.
patent: 2005/0085518 (2005-04-01), Dai et al.
patent: 2006/0052456 (2006-03-01), Autier et al.
patent: 2006/0142358 (2006-06-01), Autier et al.
patent: 2007/0066614 (2007-03-01), Pyring et al.
patent: 2008/0070905 (2008-03-01), Muchowski et al.
patent: 1249869 (1967-09-01), None
patent: 0610653 (1994-08-01), None
patent: 0 790 057 (1997-08-01), None
patent: 0819681 (1998-01-01), None
patent: 2003/292485 (2003-10-01), None
patent: WO 90/09787 (1990-09-01), None
patent: WO 93/05014 (1993-03-01), None
patent: WO 99/28306 (1999-06-01), None
patent: WO 99/28309 (1999-06-01), None
patent: WO 03/044000 (2003-05-01), None
patent: WO 03/072554 (2003-09-01), None
patent: WO 2005/103022 (2005-11-01), None
Neidlein et al., Chemical Abstracts, 69:96590, 1968.
Richter, A. et al. “The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia.”European Journal of Pharmacology, 478 (2003) 47-52.
Ingle, D.B. et al. “Synthesis of 2-sulfanilamidothiazole derivatives and their antibacterial activity”. Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; XP002549764 retrieved from STN, Database accession No. 1979:38829, J. Indian Chem. Soc. 55(1):50-51 (1978).
Joshi, K.C. et al. “Organic Pesticides. Part X. Preparation of Some 2-Amino-4-aryl-5-alkylthiazoles and Related Compounds,N-Substituted Aminothiazoles and their Mercurials, and 2-p-Fluoro-phenylimino-4- thiazolidone and its Condensation Products” Journal of the Indian Chemical Society, 39(2):121-128 (1962); XP000571711.
Khan, R.H. et al. “Synthesis of Fluoroarylthiazoles and Related Compounds as Possible Fungicides”, Agr. Biol. Chem. 40(6):1129-1135 (1976); XP001026659.
R. Schwarcz and R. Pellicciari, “Manipulation of Brain Kynurenines; Glial Targets, Neuronal Effects, and Clinical Opportunities,” The Journal of Pharmacology and Experimental Therapeutics, 303(1),1-10 (2002).
Erickson et al., A Radiometric Assay for Kynurenine 3-Hydroxylase Based on the Release of3H2O During Hydroxylation of L-[3,5-3H]-Kynurenine, Anal. Biochem. 1992, 205, 257-262.
An English translation of JP 2003-292485, Oct. 15, 2003.
Bell, F. “Investigations in the Diphenyl Series. Part IX. Further Experiments with Sulphonamides” Journal of the Chemical Society, Chemical Society, Letchworth; GB LNKD-DOI:10.1039/JR9300001071, Jan. 1, 1930, pp. 1071-1077, XP009018773 ISSN: 0368-1769.
Bouchain, G. et al. “Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivates as Histone Deacetylase Inhibitors” Journal of Medicinal Chemistry, American Chemical Society, Washington, US LNKD-DOI:10.1021/JM020377A, vol. 46, Jan. 1, 2003, pp. 820-830, XP002278212. ISSN: 0022-2623.
Bouchain, G. et al. “Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation” Current Medicinal Chemistry, Bentham Science Publishers BV, BE LNKD-DOI:10.2174/0929867033456585, vol. 10, No. 22, Jan. 1, 2003, pp. 2359-2372, XP002480700, ISSN: 0929-8673.
Case, F. H. “Nitration of certain halo biphenyls. IV. Nitro derivatives of 3-bromobiphenyl” Journal of the American Chemical Society, Coden: JACSAT; ISSN: 0002-7863, vol. 67, 1945, pp. 116-121, XP002590239.
Chemical Abstracts Registry No. 402767-36-6, indexed in the file Registry on STN Mar. 25, 2002.
Chemical Abstracts Registry No. 894531-35-2, indexed in the file Registry on STN Jul. 19, 2006.
Dhanoa, D.S., et al. “Serine Proteases-Directed Small Molecule Probe Libraries” Medicinal Chemistry Research, Birkhaeuser, Boston, US, vol. 8, No. 4/05, Jan. 1, 1998, pp. 187-205, XP009016618, ISSN: 1054-2523.
El-Hewehi, Zaki. et al. “Sulfonic acid derivatives. III. Preparation, composition, and insecticide activity of sulfonamides” Journal Fuer Praktische Chemie (LEIPZIG), 34(5-6), 218-42 Coden: JPCEAO; ISSN: 0021-8383, 1966, XP009135712.
Finn, P.W. et al. “Novel Sulfonamide Derivatives as Histone Deacetylase” Helvetica Chimica Acta, Verlag Helvetica Chimica Acta, Basel, CH LNKD-DOI:10.1002/HLCA.200590129, vol. 88, Jul. 1, 2005, pp. 1630-1657, XP002367316. ISSN: 0018-019X.
Raju, B. et al. “Solid Phase Synthesis of Sulfonamides Using a Carbamate Linker” Tetrahedron Letters, Elsevier, Amsterdam, NL LNKD-DOI:10.1016/50040-4039(97)00652-7, vol. 38, No. 19, May 12, 1997, pp. 3373-3376, XP004061429, ISSN: 0040-4039.
Somaglino, J. C. “Sulfonamides” Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; 1941, XP002590240.
Rover, et al., J. Med. Chem. 1997, 40, 4378-4385.

Affiliated with

Also associated with

Rating

Small molecule inhibitors of kynurenine-3-monooxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small molecule inhibitors of kynurenine-3-monooxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule inhibitors of kynurenine-3-monooxygenase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4316246